ARO-RAGE / Arrowhead  >>  Phase 1
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
ARO-RAGE / Arrowhead
NCT05276570 / 2022-003466-20: Study of ARO-RAGE in Healthy Subjects and Patients With Inflammatory Lung Disease

Recruiting
1
149
Europe, RoW
ARO-RAGE, Placebo
Arrowhead Pharmaceuticals, Arrowhead Pharmaceuticals, Inc.
Asthma
12/24
02/25
NCT05533294: Study of ARO-RAGE in Healthy Subjects

Completed
1
43
RoW
ARO-RAGE Injection, Placebo
Arrowhead Pharmaceuticals
Asthma
02/24
02/24

Download Options